| Identifier |
20190319_nanos_newinfo_1_05_slides |
| Title |
What is New in Migraine Treatment? |
| Creator |
Kathleen B. Digre, MD |
| Affiliation |
Moran Eye Center, University of Utah |
| Subject |
Migraine; Calcitonin Gene-Related Peptide; CGRP Receptor Antagonists; CGRP Monoclonal Antibodies; Device Therapies For Migraine |
| Description |
Migraine is very common-more common than diabetes and asthma combined. It affects almost 20% of; women and 10% of men, and will make up a large number of people visiting a neuro-ophthalmology clinic. The World Health Organization has listed migraine in the top 10 most disabling conditions. Keeping up with advances in migraine pathophysiology and treatment is almost a full-time job, but every neuro-ophthalmologist must know about these new advances in treatment since individuals will be requesting medication or presenting with migraine in the neuro-ophthalmology clinic. |
| Date |
2019-03 |
| Language |
eng |
| Format |
application/pdf |
| Format Creation |
Microsoft PowerPoint |
| Type |
Text |
| Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s61w0pnk |
| Setname |
ehsl_novel_nam |
| ID |
1539155 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s61w0pnk |
